HCW Biologics
HCWB----
HCW Biologics (HCWB)
HCW Biologics Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation,...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
HCW Biologics Analyst Rating
View MoreForecast & Rating
Jun 24, 2026Price forecast
$30.001100.00%
Forecast & RatingBuy
1analysts
- Strong buy0.00%
- Buy100.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- PUBT · Jul 23 at 07:04 AM
HCW Biologics seeks FDA pre-IND meeting for HCW11-018b T-cell engager program
- benzinga_article · Jul 20 at 07:05 AM
12 Health Care Stocks Moving In Monday's Pre-Market Session
- TradingView · Jul 1 at 07:33 AM
HCW Biologics settles $2.8M of disputed payables, removes $1.1M lien
- StockTitan · Jun 29 at 11:25 PM
HCW Biologics Regained Compliance with Bid Price Rule Per Nasdaq Compliance Letter | HCWB Stock News
- StockTitan · Jun 25 at 11:55 PM
HCW Biologics Announces 1-for-6 Reverse Stock Split Effective on June 30, 2026 | HCWB Stock News
- benzinga_article · Jun 16 at 09:20 AM
Microcap HCW Biologics' Therapy Shows Early Promise Against Autoimmune Hair Loss
